Bifogade filer
PDF
Kurs
-0,80%
Likviditet
0,05 MSEK
Kalender
| Tid* | ||
| 2024-11-22 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
| 2024-11-21 | - | Årsstämma |
| 2024-11-15 | - | Kvartalsrapport 2025-Q1 |
| 2024-08-28 | - | Bokslutskommuniké 2024 |
| 2024-05-24 | - | Kvartalsrapport 2024-Q3 |
| 2024-02-22 | - | Kvartalsrapport 2024-Q2 |
| 2023-12-14 | - | Extra Bolagsstämma 2024 |
| 2023-11-24 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
| 2023-11-23 | - | Årsstämma |
| 2023-11-17 | - | Kvartalsrapport 2024-Q1 |
| 2023-08-28 | - | Bokslutskommuniké 2023 |
| 2023-05-26 | - | Kvartalsrapport 2023-Q3 |
| 2023-05-17 | - | Extra Bolagsstämma 2023 |
| 2023-02-23 | - | Kvartalsrapport 2023-Q2 |
| 2022-11-25 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
| 2022-11-24 | - | Årsstämma |
| 2022-11-11 | - | Kvartalsrapport 2023-Q1 |
| 2022-08-26 | - | Bokslutskommuniké 2022 |
| 2022-05-20 | - | Kvartalsrapport 2022-Q3 |
| 2022-02-25 | - | Kvartalsrapport 2022-Q2 |
| 2021-11-26 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
| 2021-11-25 | - | Årsstämma |
| 2021-11-11 | - | Kvartalsrapport 2022-Q1 |
| 2021-08-27 | - | Bokslutskommuniké 2021 |
| 2021-06-17 | - | Extra Bolagsstämma 2022 |
| 2021-05-21 | - | Kvartalsrapport 2021-Q3 |
| 2021-03-02 | - | Extra Bolagsstämma 2021 |
| 2021-02-26 | - | Kvartalsrapport 2021-Q2 |
| 2020-11-27 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
| 2020-11-26 | - | Årsstämma |
| 2020-11-12 | - | Kvartalsrapport 2021-Q1 |
| 2020-08-28 | - | Bokslutskommuniké 2020 |
| 2020-05-22 | - | Kvartalsrapport 2020-Q3 |
| 2020-02-28 | - | Kvartalsrapport 2020-Q2 |
| 2019-11-22 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
| 2019-11-21 | - | Årsstämma |
| 2019-11-08 | - | Kvartalsrapport 2020-Q1 |
| 2019-08-30 | - | Bokslutskommuniké 2019 |
| 2019-05-17 | - | Kvartalsrapport 2019-Q3 |
| 2019-02-15 | - | Kvartalsrapport 2019-Q2 |
| 2018-11-16 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
| 2018-11-15 | - | Årsstämma |
| 2018-11-09 | - | Kvartalsrapport 2019-Q1 |
| 2018-08-30 | - | Bokslutskommuniké 2018 |
| 2018-05-18 | - | Kvartalsrapport 2018-Q3 |
| 2018-02-16 | - | Kvartalsrapport 2018-Q2 |
| 2017-11-10 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
| 2017-11-09 | - | Årsstämma |
| 2017-11-02 | - | Kvartalsrapport 2018-Q1 |
| 2017-08-18 | - | Bokslutskommuniké 2017 |
| 2017-05-12 | - | Kvartalsrapport 2017-Q3 |
| 2017-02-10 | - | Kvartalsrapport 2017-Q2 |
| 2017-01-19 | - | Extra Bolagsstämma 2018 |
| 2016-11-18 | - | Kvartalsrapport 2017-Q1 |
| 2016-11-11 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
| 2016-11-10 | - | Årsstämma |
| 2016-08-19 | - | Bokslutskommuniké 2016 |
| 2016-05-13 | - | Kvartalsrapport 2016-Q3 |
| 2016-02-12 | - | Kvartalsrapport 2016-Q2 |
| 2015-11-13 | - | Kvartalsrapport 2016-Q1 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Spotlight |
| Sektor | Hälsovård |
| Industri | Bioteknik |
Hamlet BioPharma, the innovative pharmaceutical company currently advancing several phase II trials targeting infectious diseases and cancer, along with an extensive project and patent portfolio, is delighted toinvite you to join a presentation at Invest Live, on Tuesday December 12[th] at 12.00 CET.
Gain insights into the company's latest progress within its infectious disease and cancer therapy, which includes 'Fast Track' status for the company's cancer-drug Alpha1H.
We welcome share holders, investors and other interested parties to join the presentation and discussion.
The presentation will be held in English.
Use this link to view the presentation:
For further information, please contact:
Catharina Svanborg, Chairman and Founder of Hamlet BioPharma, +46-709 42 65 49
catharina.svanborg@hamletpharma.com
Martin Erixon, CEO Hamlet BioPharma, +46-733 00 43 77
martin.erixon@hamletpharma.com
www.hamletbiopharma.com